Immatics N.V.
IMTX • NASDAQ
Immatics N.V. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Harpreet Singh, with a market cap of $1.4B.
Market Cap$1.4B
Employees343.0
CEOHarpreet Singh
CountryGermany
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
Immatics N.V. FAQ
Common questions about Immatics N.V.
Immatics N.V. is scheduled to report earnings for Q1 2026 on May 12, 2026. Analysts estimate revenue of $14.6M.
Immatics N.V. has approximately 343 employees.